Bill Aurora, Pharm.D.

Bill Aurora, Pharm.D.

Chief Strategy OfficeratNeumora Therapeutics· In proxies 2023–2025

Pay in FY2025-37% from the year before · Neumora Therapeutics stock -83.1% the same year

Bill Aurora, Pharm.D. was paid $3.3M in FY2025 (Dec), down 37%. Neumora Therapeutics stock fell 83.1% that year.

Pay$100 in the stock at the end of FY23 → $10
Pay is from the Summary Compensation Table of each Neumora Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Neumora TherapeuticsPublic company · 3 yr
    • Chief Strategy Officer2023 – Present · 3 yrStock in role -98%

Roles come from the proxy statements of each company.

Activity

Two people shown as one, or a wrong number?